Drugs / MODITHROMYCIN
MODITHROMYCIN
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00270517 | Dec 2005 → Jul 2007 | — | Enanta Pharmaceuticals, Inc | Unknown | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MODITHROMYCIN | ChEMBL registry synonym — accepted as the source's own label CHEMBL263886 ↗ |
| Known as | Edp-013420 | ChEMBL registry synonym — accepted as the source's own label CHEMBL263886 ↗ |
| Known as | EDP-420 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00270517 ↗ |
| Known as | EP-13420 | ChEMBL registry synonym — accepted as the source's own label CHEMBL263886 ↗ |
| Known as | Modithromycine | ChEMBL registry synonym — accepted as the source's own label CHEMBL263886 ↗ |
| Known as | Moditromicina | ChEMBL registry synonym — accepted as the source's own label CHEMBL263886 ↗ |
| Modality | Small molecule | — CHEMBL263886 ↗ |